Blessing, John A.

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study

Rose, P. G., Blessing, J. A., Mayer, A. R., & Homesley, H. D. (1998) · Journal of Clinical Oncology

Ovarian cancer diagnosis and treatmentEndometrial and Cervical Cancer Treatments

Cited by 386

Echinomycin in Recurrent and Metastatic Endometrial Carcinoma: A Phase II Trial of the Gynecologic Oncology Group

Muss, H. B., Blessing, J. A., & DuBeshter, B. (1993) · American Journal of Clinical Oncology

Endometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatment

Cited by 33

Echinomycin (NSC 526417) in Advanced Ovarian Cancer: A Phase II Trial of the Gynecologic Oncology Group

Muss, H. B., Blessing, J. A., Baker, V. V., Barnhill, D. R., & Adelson, M. D. (1990) · American Journal of Clinical Oncology

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapy

Cited by 18

Echinomycin (NSC 526417) in Squamous-Cell Carcinoma of the Cervix: A Phase II Trial of the Gynecologic Oncology Group

Muss, H. B., Blessing, J. A., & Malfetano, J. (1990) · American Journal of Clinical Oncology

Endometrial and Cervical Cancer TreatmentsCervical Cancer and HPV Research

Cited by 11